Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Nautilus Biotechnology Inc fell by 95.08m. Cash Flow from Financing totalled 368.00k or -- of revenues. In addition the company used 51.71m for operations while cash used for investing totalled 43.74m.
Cash flow per share | -0.5442 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.78 |
---|---|
Tangible book value per share | 1.78 |
More ▼
Balance sheet in USDView more
Current ratio | 16.65 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼